WarfarinAnticoagulantsAcenocoumarolbeta-AlanineInternational Normalized RatioProthrombin TimeAdministration, OralThromboembolismHemorrhageVitamin KPhenindionePhenprocoumonVitamin K Epoxide ReductasesAtrial FibrillationThiophenesPyridonesThrombophlebitisBlood CoagulationBenzimidazolesAntithrombinsBlood Coagulation TestsVenous ThromboembolismFactor XaDrug MonitoringHeparin, Low-Molecular-WeightThrombosisProthrombinPartial Thromboplastin TimeHeparinVenous ThrombosisLupus Coagulation InhibitorProtein CAspirinRodenticidesBlood Coagulation FactorsPulmonary EmbolismMorpholinesPlatelet Aggregation InhibitorsStrokeFibrinolytic Agents4-HydroxycoumarinsCoumarinsThrombophiliaBlood Coagulation DisordersPharmacogeneticsMixed Function OxygenasesEmbolismTreatment OutcomeDicumarolFactor XEnoxaparinHematomaOral Surgical ProceduresThrombinDrug InteractionsCoagulantsThromboplastinPostoperative HemorrhageIntracranial HemorrhagesAryl Hydrocarbon HydroxylasesHeart Valve ProsthesisPyrazolesThrombin TimeCerebral HemorrhageAzetidinesPerioperative CareFactor VIIProtein SRisk FactorsRandomized Controlled Trials as TopicTime FactorsRecurrenceHemostasis